{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:21:13Z","timestamp":1776864073840,"version":"3.51.2"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2385175","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:42:15Z","timestamp":1724132535000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Cost\u2013benefit analysis of the National Immunization Program in Spain"],"prefix":"10.1080","volume":"20","author":[{"given":"Alberto","family":"P\u00e9rez","sequence":"first","affiliation":[{"name":"Hospital Nuestra Se\u00f1ora De Sonsoles (Complejo Asistencial De Avila)","place":["\u00c1vila, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez Prada","sequence":"additional","affiliation":[{"name":"Hospital Vital Alvarez Buylla","place":["Asturias, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Cassinello","sequence":"additional","affiliation":[{"name":"Universidad Pontificia Comillas","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-0835","authenticated-orcid":false,"given":"Laura Amanda","family":"Vallejo-Aparicio","sequence":"additional","affiliation":[{"name":"GSK","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-6526","authenticated-orcid":false,"given":"Andrea","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"GSK","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Vivactis Weber","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Dur\u00e1n","sequence":"additional","affiliation":[{"name":"Vivactis Weber","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9boa","family":"Zozaya","sequence":"additional","affiliation":[{"name":"Vivactis Weber","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Vivactis Weber","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Daheron","sequence":"additional","affiliation":[{"name":"Vivactis Weber","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Hidalgo","sequence":"additional","affiliation":[{"name":"Weber Foundation","place":["Madrid, Spain"]},{"name":"University of Castilla La Mancha","place":["Toledo, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Beck","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Garc\u00eda Ruiz","sequence":"additional","affiliation":[{"name":"Universidad de M\u00e1laga \u2013 IBIMA Platform Bionand","place":["M\u00e1laga, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"World Health Organization (WHO). Vaccines and immunization. 2022. [accessed 2023 Apr 5]. https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.5546\/aap.2017.eng.432"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-018-0081-4"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vacun.2015.02.002"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1182275"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.4321\/S1135-57272020000100016"},{"key":"e_1_3_6_8_1","unstructured":"Ministerio de Sanidad Consejo Interterritorial del Sistema Nacional de Salud (CISNS) Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida: Calendario recomendado a\u00f1o 2020. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/calendario\/calendario\/docs\/CalendarioVacunacion_Todalavida_2020.pdf."},{"key":"e_1_3_6_9_1","unstructured":"Ministerio de Sanidad Consejo Interterritorial del Sistema Nacional de Salud (CISNS) Recomendaciones de vacunaci\u00f3n frente a herpes z\u00f3ster. Ponencia de Programa y Registro de Vacunaciones 2020. 2021. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/docs\/HerpesZoster_RecomendacionesVacunacion.pdf."},{"key":"e_1_3_6_10_1","unstructured":"Instituto Nacional de Estad\u00edstica (INEbase) Estad\u00edsticas de padr\u00f3n continuo Principales series de poblaci\u00f3n desde 1998. Poblaci\u00f3n por Comunidades edad (a\u00f1o a a\u00f1o) Espa\u00f1oles\/Extranjeros sexo y a\u00f1o. 2020. [accessed 2023 Apr 7]. https:\/\/www.ine.es\/jaxi\/Tabla.htm?path=\/t20\/e245\/p08\/l0\/&file=02003.px&L=0."},{"key":"e_1_3_6_11_1","unstructured":"Instituto Nacional de Estad\u00edstica (INE) Tablas de mortalidad por a\u00f1o sexo edad y funciones. 2019. [accessed 2023 Apr 7]. https:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=27153."},{"key":"e_1_3_6_12_1","unstructured":"Instituto Nacional de Estad\u00edstica (INE). INEbase Demograf\u00eda y Poblaci\u00f3n Fen\u00f3menos demogr\u00e1ficos Indicadores demog\u00e1ficos b\u00e1sicos Mortalidad Indicadores de mortalidad Esperanza de Vida al Nacimiento seg\u00fan sexo. 2019. [accessed 2023 Apr 7]. https:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=1414."},{"key":"e_1_3_6_13_1","unstructured":"Direcci\u00f3n General de Salud P\u00fablica Consejer\u00eda de Sanidad Inclusi\u00f3n de la vacuna frente a herpes z\u00f3ster (HZ) en el calendario sistem\u00e1tico de vacunaci\u00f3n. Informaci\u00f3n para profesionales sanitarios. 2022. [accessed 2023 Apr 7]. https:\/\/www.comunidad.madrid\/sites\/default\/files\/doc\/sanidad\/prev\/doc_tecnico_vacunacion_frente_a_herpes_zoster_en_la_cm.pdf."},{"key":"e_1_3_6_14_1","unstructured":"Gobierno del Principado de Asturias Nota de prensa. Mi\u00e9rcoles 15 de junio de 2022. Salud incluye en el calendario vacunal de adultos la profilaxis del herpes z\u00f3ster para grupos de riesgo y personas de 65 a\u00f1os. 2022. [accessed 2023 Apr 7]. https:\/\/www.astursalud.es\/documents\/35439\/797507\/2022_06_15%20NP%20Herpes%20Zoster%20calendario%20vacunal%20adulto.pdf\/0df66a61-fa1c-1f58-160b-847b953e3e11."},{"key":"e_1_3_6_15_1","unstructured":"Ministerio de sanidad consejo Interterritorial del Sistema Nacional de Salud (CISNS) Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida - calendario recomendado a\u00f1o. 2022. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/calendario\/calendario\/docs\/CalendarioVacunacion_Todalavida_2022.pdf."},{"key":"e_1_3_6_16_1","unstructured":"Ministerio de sanidad consejo Interterritorial del Sistema Nacional de Salud (CISNS) Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida - calendario recomendado a\u00f1o. 2023. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/calendario\/docs\/CalendarioVacunacion_Todalavida.pdf."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2020.10.002"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2380-2"},{"key":"e_1_3_6_19_1","unstructured":"Direcci\u00f3n General de Salud P\u00fablica y Ordenaci\u00f3n Farmac\u00e9utica Servicio Andaluz de Salud Instrucci\u00f3n DGSPYOF-9\/2021. Calendario de Vacunaciones Andaluc\u00eda 2021-2022. 2021. [accessed 2023 Apr 7]. https:\/\/www.juntadeandalucia.es\/export\/drupaljda\/Instruccion-DGSPyOF_9_2021-Calendario-Vacunaciones-Andalucia-2021_22.pdf."},{"key":"e_1_3_6_20_1","unstructured":"Bolet\u00edn Oficial de Canarias BOC - 2019\/126. Mi\u00e9rcoles 3 de julio de 2019 - Anuncio 3325. 3325 ORDEN de 28 de junio de 2019 por la que se aprueba el Calendario Vacunal para todas las edades de la vida en la Comunidad Aut\u00f3noma de Canarias. 2019. [accessed 2023 Apr 7]. http:\/\/www.gobiernodecanarias.org\/boc\/2019\/126\/001.html."},{"key":"e_1_3_6_21_1","unstructured":"Bolet\u00edn Oficial de Castilla y Le\u00f3n BOCYL n.o 78 del 25 de abril 2019. ORDEN SAN\/386\/2019 de 15 de abril por la que se modifica el Calendario Oficial de Vacunaciones Sistem\u00e1ticas a lo largo de la vida de las personas para la Comunidad de Castilla y Le\u00f3n. 2019. [accessed 2023 Apr 7]. https:\/\/bocyl.jcyl.es\/boletines\/2019\/04\/25\/pdf\/BOCYL-D-25042019-41.pdf."},{"key":"e_1_3_6_22_1","unstructured":"Diari Oficial de la Generalitat de Catalunya Ordre SLT\/46\/2022 de 22 de mar\u00e7 per la qual s\u2019actualitza el calendari de vacunacions sistem\u00e0tiques. 2022. [accessed 2023 Apr 7]. http:\/\/cido.diba.cat\/legislacio\/13095313\/ordre-slt462022-de-22-de-marc-per-la-qual-sactualitza-el-calendari-de-vacunacions-sistematiques-departament-de-salut."},{"key":"e_1_3_6_23_1","unstructured":"Sociedad Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda Recomendaciones de vacunaci\u00f3n para adultos y mayores y calendarios vacunales 2019-2020. 2020. [accessed 2023 Jul 3]. https:\/\/www.segg.es\/media\/descargas\/VACUNAS-SEGG-2019-2020.pdf."},{"key":"e_1_3_6_24_1","unstructured":"Sociedad Espa\u00f1ola de M\u00e9dicos Generales y de Familia (SEMG) Folleto informativo: vacunaci\u00f3n de tosferina en adultos. 2021. [accessed 2023 Jul 3]. http:\/\/www.semg.es\/images\/stories\/Informacion_Tosferina_OPT.pdf."},{"key":"e_1_3_6_25_1","unstructured":"Centro Nacional de Epidemiolog\u00eda (CIBERESP) Instituto de Salud Carlos III Informe epidemiol\u00f3gico sobre la situaci\u00f3n del Herpes Z\u00f3ster en Espa\u00f1a 1998-2018. 2020. [accessed 2023 Apr 7]. https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/HERPES%20ZOSTER\/Informe_HZ_Espa%C3%B1a_1998-2018.pdf."},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.029"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2009.07.011"},{"key":"e_1_3_6_28_1","unstructured":"Puig-Junoy JO-M Trapero-Bertr\u00e1n M Abell\u00e1n-Perpi\u00f1\u00e1n JM Brosa-Riestra M. Servei Catal\u00e0 de la Salut (CatSalut) Gu\u00eda y recomendaciones para la realizaci\u00f3n y presentaci\u00f3n de evaluaciones econ\u00f3micas y an\u00e1lisis de impacto presupuestario de medicamentos en el \u00e1mbito del CatSalut. Generalitat de Catalunya. Departament de Salut. Servei Catal\u00e0 de la Salut: Barcelona. 2014. [accessed 2023 Jul 3]. https:\/\/catsalut.gencat.cat\/web\/.content\/minisite\/catsalut\/proveidors_professionals\/medicaments_farmacia\/farmaeconomica\/caeip\/gaeip_publica_castellano_octubre2014_catsalut.pdf."},{"key":"e_1_3_6_29_1","unstructured":"Ortega EAM Fraga Fuentes MD L\u00f3pez-Briz E Puigvent\u00f3s LF. Gu\u00eda de evaluaci\u00f3n econ\u00f3mica e impacto presupuestario en los informes de evaluaci\u00f3n de medicamentos. 2017. [accessed 2023 Jul 3]. https:\/\/gruposdetrabajo.sefh.es\/genesis\/genesis\/Documents\/Introduccion_A_Ortega.pdf."},{"key":"e_1_3_6_30_1","unstructured":"Sanidad MD. Gu\u00eda de Evaluaci\u00f3n Econ\u00f3mica de Medicamentos. 2024. [accessed 2024 June 5]. https:\/\/www.sanidad.gob.es\/areas\/farmacia\/comitesAdscritos\/prestacionFarmaceutica\/docs\/20240227_CAPF_Guia_EE_definitiva.pdf."},{"key":"e_1_3_6_31_1","unstructured":"Instituto Nacional de Estad\u00edstica (INE) \u00cdndice de Precios de Consumo. Base 2016 Medias anuales. \u00cdndices nacionales: general y de grupos ECOICOP. 2020. [accessed 2023 Apr 7]. http:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=22553."},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826010-00005"},{"key":"e_1_3_6_33_1","unstructured":"Consejo General de Colegios Farmac\u00e9uticos BOT Plus 2. Base de Datos de Medicamentos. 2022. [accessed 2023 Apr 7]. https:\/\/botplusweb.portalfarma.com\/."},{"key":"e_1_3_6_34_1","unstructured":"Ministerio de Sanidad Evoluci\u00f3n coberturas de vacunaci\u00f3n frente a sarampi\u00f3n rubeola y parotiditis (TV) y virus del papiloma humano (VPH). Espa\u00f1a 2010-2020. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Tabla3.pdf."},{"key":"e_1_3_6_35_1","unstructured":"Ministerio de Sanidad Evoluci\u00f3n coberturas de vacunaci\u00f3n de recuerdo. Espa\u00f1a 2010-2020. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Todas_las_tablas2020.pdf."},{"key":"e_1_3_6_36_1","unstructured":"Ministerio de Sanidad Evoluci\u00f3n coberturas de primovacunaci\u00f3n. Espa\u00f1a 2010-2020. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Todas_las_tablas2020.pdf."},{"key":"e_1_3_6_37_1","unstructured":"Ministerio de Sanidad Coberturas de vacunaci\u00f3n frente a gripe en \u226565 a\u00f1os en \u226575 a\u00f1os personas de personas de 65-74 a\u00f1os personas de personas de 60-64 a\u00f1os embarazadas y personal sanitario. Comunidades aut\u00f3nomas. Campa\u00f1a 2020-2021. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Tabla13.pdf."},{"key":"e_1_3_6_38_1","unstructured":"Ministerio de Sanidad Coberturas de vacunaci\u00f3n de primera y segunda dosis de recuerdo y de vacunaci\u00f3n en adolescentes susceptibles con varicela. Comunidades aut\u00f3nomas. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/va\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Tabla10.pdf."},{"key":"e_1_3_6_39_1","unstructured":"Ministerio de Sanidad Coberturas de vacunaci\u00f3n con dTpa en embarazadas. Comunidades aut\u00f3nomas. A\u00f1o 2020. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Todas_las_tablas2020.pdf."},{"key":"e_1_3_6_40_1","unstructured":"Ministerio de Sanidad Coberturas de primovacunaci\u00f3n y dosis de recuerdo frente a neumococo. Comunidades Aut\u00f3nomas. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Todas_las_tablas2020.pdf."},{"key":"e_1_3_6_41_1","unstructured":"Ministerio de Sanidad Coberturas de vacunaci\u00f3n frente a meningitis C y meninigitis ACWY en adolescentes. Comunidades Aut\u00f3nomas. 2020. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Todas_las_tablas2020.pdf."},{"key":"e_1_3_6_42_1","unstructured":"Consejeria de Sanidad Junta de Castilla y Le\u00f3n Cobertura de vacunaciones. 2020. [accessed 2023 Apr 7]. https:\/\/www.saludcastillayleon.es\/profesionales\/es\/vacunaciones\/coberturas-vacunacion.ficheros\/2607109-Coberturas CyL a%C3%B1o 2020 11122023.pdf."},{"key":"e_1_3_6_43_1","unstructured":"Ministerio de Hacienda y Funci\u00f3n P\u00fablica Plataforma de Contrataci\u00f3n del Sector P\u00fablico. 2022. [accessed 2023 Apr 7]. https:\/\/contrataciondelestado.es\/wps\/portal\/licitaciones."},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.100"},{"key":"e_1_3_6_45_1","unstructured":"GSK Changing attitudes to vaccination after the COVID-19 pandemic could increase adult vaccination rates improving health outcomes over the longer term. 2021. [accessed 2023 Apr 7]. https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/changing-attitudes-to-vaccination-after-the-covid-19-pandemic-could-increase-adult-vaccination-rates-improving-health-outcomes-over-the-longer-term\/."},{"key":"e_1_3_6_46_1","unstructured":"Organisation for Economic Co-operation and Development (OECD). Ready for the next crisis? Investing in health system resilience. 2023. [accessed 2023 Jul 3]. https:\/\/www.oecd.org\/content\/dam\/oecd\/en\/publications\/reports\/2023\/02\/ready-for-the-next-crisis-investing-in-health-system-resilience_a8424ec8\/1e53cf80-en.pdf."},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-022-00329-3"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2019.1588470"},{"key":"e_1_3_6_49_1","unstructured":"European Commission (EC). 2024 Ageing Report. Economic & Budgetary Projections for the EU Member States (2022-2070). INSTITUTIONAL PAPER 279 | APRIL 2024. 2023. [accessed 2024 Aug 14].https:\/\/economy-finance.ec.europa.eu\/document\/download\/971dd209-41c2-425d-94f8-e3c3c3459af9_en?filename=ip279_en.pdf."},{"key":"e_1_3_6_50_1","volume-title":"Chapter 2. Ageing and productivity growth in OECD regions: combatting the economic impact of ageing through productivity growth?","author":"Daniele F","year":"2019","unstructured":"Daniele F, Honiden T, Lembcke A. Chapter 2. Ageing and productivity growth in OECD regions: combatting the economic impact of ageing through productivity growth? Paris: OECD Publishing; 2019."},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.09.039"},{"key":"e_1_3_6_52_1","unstructured":"Gobierno de Espa\u00f1a Ministerio de Sanidad del Carmen Rodr\u00edguez Blas M Estad\u00edstica de gasto sanitario p\u00fablico 2021: Principales resultados. Marzo de. 2022. [accessed 2023 Apr 7]. https:\/\/www.sanidad.gob.es\/estadEstudios\/estadisticas\/docs\/EGSP2008\/egspPrincipalesResultados.pdf."},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-056007"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x13493142"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60532-7"},{"key":"e_1_3_6_56_1","unstructured":"Higgins JPT Green S. Cochrane handbook for systematic reviews of interventions v5.1.0. Chapter 15. Meta-analysis of resource use and cost data. 2011. [accessed 2023 Apr 7]. https:\/\/www.radioterapiaitalia.it\/wp-content\/uploads\/2017\/01\/cochrane-handbook-for-systematic-reviews-of-interventions.pdf."},{"issue":"6","key":"e_1_3_6_57_1","first-page":"757","article-title":"Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity","volume":"70","author":"Ginsberg GM","year":"1992","unstructured":"Ginsberg GM, Berger S, Shouval D. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity. Bull World Health Organ. 1992;70(6):757\u201367.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_6_58_1","first-page":"193","article-title":"Cost-effectiveness analysis of pneumococcal vaccination in the elderly Spanish population","volume":"10","author":"Jimenez FJ","year":"1996","unstructured":"Jimenez FJ, Guallar P, Rubio C, Villasante P, Guallar E. Cost-effectiveness analysis of pneumococcal vaccination in the elderly Spanish population. Br J Med Econ. 1996;10:193\u2013202.","journal-title":"Br J Med Econ"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2385175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:18:57Z","timestamp":1744651137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2385175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2385175"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2385175","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2385175"}}